Page 12 - Inivata Invision News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inivata invision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inivata Invision Today - Breaking & Trending Today

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing


Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing
Published: 08:45, 08 February 2021
A highly sensitive test for minimal residual disease (MRD) - which can lead to relapses for cancer patients - will be further developed by Inivata after it raised $35million (£25.7m) in a second close of a Series C financing round.
The liquid biopsy pioneer, based at the Babraham Research Campus and Research Triangle Park in North Carolina, USA, said it will accelerate the clinical development and roll-out of RaDaR, its personalised assay to detect and monitor MRD and recurrence.
Clive Morris, CEO at Inivata ....

United States , United Kingdom , North Carolina , Research Triangle Park , Clive Morris , Inivata Invision , Guy Levy , University Of Cambridge , Cancer Research United Kingdom Cambridge Institute , Ip Group , Babraham Research Campus , Connecticut Based Soleus Capital , Janus Henderson Investors , Farallon Capital , Soleus Capital , Business News , Life Science , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , வடக்கு கரோலினா , ஆராய்ச்சி முக்கோணம் பூங்கா , கிளைவ் மோரிஸ் , பையன் வசூல் செய்தல் , பல்கலைக்கழகம் ஆஃப் கேம்பிரிட்ஜ் , புற்றுநோய் ஆராய்ச்சி ஒன்றுபட்டது கிஂக்டம் கேம்பிரிட்ஜ் நிறுவனம் , இப் குழு ,

Inivata's Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer


News Category Global Banking & Finance Reviews
Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer
Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for
Early Detection of Lung Cancer
Research Collaboration to be led by the University of Southampton and
along with several major diagnostics and informatics companies will test the best way of detecting cancers at a stage when they can still be cured
Inivata’s InVision
Liquid Biopsy platform will be used to detect mutations in ctDNA in study participants
Research Triangle Park, NC, USA and Cambridge, UK, 18 December 2020 – Inivata, a leader in liquid biopsy, today announces its participation in a major research collaboration to investigate integrated diagnostics for the early detection of lung cancer with the aim of increasing survival rates, alongside improving the efficiency of testing in peo ....

United States , United Kingdom , Clive Morris , Peter Johnson , Karen Chandler Smith , Inivata Invision , Cancer Research United Kingdom Cambridge Institute , University Of Southampton , Lung Cancer Initiative At Johnson , United Kingdom Government Early Diagnosis Mission , Research Collaboration , University Of Cambridge , Research Triangle Park , University Of Leeds , Liquid Biopsy Technology Included , Early Detection , Liquid Biopsy , Triangle Park , Lung Cancer Initiative , United Kingdom Government , Early Diagnosis Mission , Medical Oncology , Consilium Strategic Communications Chris , Sarah Wilson Paul Kidwell , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,